Cargando…
Unlocking the Value of Anti-TNF Biosimilars: Reducing Disease Burden and Improving Outcomes in Chronic Immune-Mediated Inflammatory Diseases: A Narrative Review
Immune-mediated inflammatory diseases (IMIDs) are chronic conditions that create a significant disease burden on millions of patients while adding a major financial burden to societies and healthcare systems. The introduction of biologic medicines has contributed majorly to improving the clinical ou...
Autores principales: | Rezk, Mourad F., Pieper, Burkhard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7444394/ https://www.ncbi.nlm.nih.gov/pubmed/32740789 http://dx.doi.org/10.1007/s12325-020-01437-4 |
Ejemplares similares
-
Correction to: Unlocking the Value of Anti-TNF Biosimilars: Reducing Disease Burden and Improving Outcomes in Chronic Immune-Mediated Inflammatory Diseases: A Narrative Review
por: Rezk, Mourad F., et al.
Publicado: (2020) -
Treatment Outcomes with Biosimilars: Be Aware of the Nocebo Effect
por: Rezk, Mourad F., et al.
Publicado: (2017) -
To See or NOsee: The Debate on the Nocebo Effect and Optimizing the Use of Biosimilars
por: Rezk, Mourad F., et al.
Publicado: (2018) -
Correction to: To See or NOsee: The Debate on the Nocebo Effect and Optimizing the Use of Biosimilars
por: Rezk, Mourad F., et al.
Publicado: (2018) -
An Introduction to Biosimilars for the Treatment of Retinal Diseases: A Narrative Review
por: Hariprasad, Seenu M., et al.
Publicado: (2022)